New quantitative three-dimensional echocardiographic indices of mitral valve stenosis

Valočík, Gabriel; Kamp, Otto; Mannaerts, Herman F.J.; Visser, Cees A.

doi:10.1007/s10554-007-9211-2

Cited by 19 publications

(8 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The detection of high blood pressure without hypertrophy should lead to consideration of overestimation of the severity of hypertension, including ambulatory blood pressure monitoring or measurement of central aortic pressure. 195 When there is apparent LV hypertrophy in the setting of apparent blood pressure control, more detailed blood pressure evaluation (e.g. for masked hypertension) or identifying other causes of wall thickening such as infiltrative diseases should be considered.…”

Section: Role In Decisions To Intensify Treatmentmentioning

confidence: 99%

Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†

Marwick

Gillebert

Aurigemma

et al. 2015

Journal of the American Society of Echocardiography

411

345

View full text Add to dashboard Cite

Hypertension remains a major contributor to the global burden of disease. The measurement of blood pressure continues to have pitfalls related to both physiological aspects and acute variation. As the left ventricle (LV) remains one of the main target organs of hypertension, and echocardiographic measures of structure and function carry prognostic information in this setting, the development of a consensus position on the use of echocardiography in this setting is important. Recent developments in the assessment of LV hypertrophy and LV systolic and diastolic function have prompted the preparation of this document. The focus of this work is on the cardiovascular responses to hypertension rather than the diagnosis of secondary hypertension. Sections address the pathophysiology of the cardiac and vascular responses to hypertension, measurement of LV mass, geometry, and function, as well as effects of treatment.

show abstract

Section: Role In Decisions To Intensify Treatmentmentioning

confidence: 99%

Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†

Marwick

Gillebert

Aurigemma

et al. 2015

Journal of the American Society of Echocardiography

411

345

View full text Add to dashboard Cite

show abstract

“…In addition, 3D imaging allows a more comprehensive assessment of the mitral valve and the subvalvular apparatus as was apparent from the very early studies utilizing 3D echocardiography . Studies are quite consistent in describing high feasibility (88%–100%) and reproducibility of this approach . Table presents data for comparative studies excluding the studies that used 3D‐guided 2D planimetry as the reference method .…”

Section: Mitral Stenosismentioning

confidence: 97%

Echocardiographic 3D‐guided 2D planimetry in quantifying left‐sided valvular heart disease

Argulian

Seetharam

2018

Echocardiography

View full text Add to dashboard Cite

Echocardiographic 3D-guided 2D planimetry can improve the accuracy of valvular disease assessment. Acquisition of 3D pyramidal dataset allows subsequent multiplanar reconstruction with accurate orthogonal plane alignment to obtain the correct borders of an anatomic orifice or flow area. Studies examining the 3D-guided 2D planimetry approach in left-sided valvular heart disease were identified and reviewed. The strongest evidence exists for estimating mitral valve area in patients with rheumatic mitral valve stenosis and vena contracta area in patients with mitral regurgitation (both primary and secondary). 3D-guided approach showed excellent feasibility and reproducibility in most studies, as well as time efficiency and good correlation with reference and comparator methods. Therefore, 3D-guided 2D planimetry can be used as an important clinical tool in quantifying left-sided valvular heart disease, especially mitral valve disorders.

show abstract

“…However, 2D echocardiography can only minimally visualize the entire MV and the subvalvular apparatus, resulting in erroneous measurement of the smallest valve area. Three-dimensional echocardiography has been reported to be superior to conventional 2D echocardiography for determining the smallest area and visualizing morphological abnormalities [6,29,32,69,70,71,72,73,74,75,76,77,78]. In an early study, 3D echocardiography provided accurate and highly reproducible measurements of the mitral valve area (MVA) and was easily performed via an apical approach [70].…”

Section: Mitral Stenosismentioning

confidence: 99%

Role of modern 3D echocardiography in valvular heart disease

Shiota

2014

Korean J Intern Med

View full text Add to dashboard Cite

Three-dimensional (3D) echocardiography has been conceived as one of the most promising methods for the diagnosis of valvular heart disease, and recently has become an integral clinical tool thanks to the development of high quality real-time transesophageal echocardiography (TEE). In particular, for mitral valve diseases, this new approach has proven to be the most unique, powerful, and convincing method for understanding the complicated anatomy of the mitral valve and its dynamism. The method has been useful for surgical management, including robotic mitral valve repair. Moreover, this method has become indispensable for nonsurgical mitral procedures such as edge to edge mitral repair and transcatheter closure of paravaluvular leaks. In addition, color Doppler 3D echo has been valuable to identify the location of the regurgitant orifice and the severity of the mitral regurgitation. For aortic and tricuspid valve diseases, this method may not be quite as valuable as for the mitral valve. However, the necessity of 3D echo is recognized for certain situations even for these valves, such as for evaluating the aortic annulus for transcatheter aortic valve implantation. It is now clear that this method, especially with the continued development of real-time 3D TEE technology, will enhance the diagnosis and management of patients with these valvular heart diseases.

show abstract

New quantitative three-dimensional echocardiographic indices of mitral valve stenosis

Cited by 19 publications

References 30 publications

Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†

Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†

Echocardiographic 3D‐guided 2D planimetry in quantifying left‐sided valvular heart disease

Role of modern 3D echocardiography in valvular heart disease

Contact Info

Product

Resources

About